Cite
Turner AR, Lane BR, Rogers D, et al. Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men. Cancer. 2016;122(22):3564-3575doi: 10.1002/cncr.30162.
Turner, A. R., Lane, B. R., Rogers, D., Lipkus, I., Weaver, K., Danhauer, S. C., Zhang, Z., Hsu, F. C., Noyes, S. L., Adams, T., Toriello, H., Monroe, T., McKanna, T., Young, T., Rodarmer, R., Kahnoski, R. J., Tourojman, M., Kader, A. K., Zheng, S. L., Baer, W., & Xu, J. (2016). Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men. Cancer, 122(22), 3564-3575. https://doi.org/10.1002/cncr.30162
Turner, Aubrey R, et al. "Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men." Cancer vol. 122,22 (2016): 3564-3575. doi: https://doi.org/10.1002/cncr.30162
Turner AR, Lane BR, Rogers D, Lipkus I, Weaver K, Danhauer SC, Zhang Z, Hsu FC, Noyes SL, Adams T, Toriello H, Monroe T, McKanna T, Young T, Rodarmer R, Kahnoski RJ, Tourojman M, Kader AK, Zheng SL, Baer W, Xu J. Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men. Cancer. 2016 Nov 15;122(22):3564-3575. doi: 10.1002/cncr.30162. Epub 2016 Jul 19. PMID: 27433786; PMCID: PMC5247411.
Copy
Download .nbib